The efficacy of rituximab in pediatric patients with steroid-dependent or frequent relapsing nephrotic syndrome due to MCD or FSGS

BackgroundRituximab has been shown efficacy in reducing relapses among patients with steroid-dependent or frequently relapsing nephrotic syndrome (SDNS/FRNS), primarily due to minimal change disease (MCD) or focal segmental glomerulosclerosis (FSGS). However, whether its efficacy differs between the...

Полное описание

Библиографические подробности

Главные авторы:	Yue Xi, Ying Liang, Zhi Chen, Lei Lei, Lan Mi, Xiaoyu Tian, Liuyu Sun, Qiang Sun, Nan Zhou
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Frontiers Media S.A. 2026-04-01
Серии:	Frontiers in Medicine
Предметы:	children frequent relapsing nephrotic syndrome minimal change disease primary focal segmental glomerulosclerosis rituximab steroid-dependent nephrotic syndrome
Online-ссылка:	https://www.frontiersin.org/articles/10.3389/fmed.2026.1763615/full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!